Advertisement

Acute Leukemias II

Prognostic Factors and Treatment Strategies

  • T. Büchner
  • G. Schellong
  • W. Hiddemann
  • J. Ritter
Conference proceedings

Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 33)

Table of contents

  1. Front Matter
    Pages I-XXXI
  2. Leukemia Cell Biology and Basic Science

    1. Front Matter
      Pages 1-1
    2. C. R. Bartram, J. W. G. Janssen
      Pages 17-22
    3. A. Hagemeijer, D. C. van der Plas
      Pages 23-30
    4. S. Slavin, A. Eckerstein, I. Hardan, M. Ben Shahar, R. Or, E. Naparstek et al.
      Pages 36-40
    5. H. J. Adriaansen, H. Hooijkaas, M. C. Kappers-Klunne, K. Hählen, M. B. van’t Veer, J. J. M. van Dongen
      Pages 41-49
    6. M. Volkmann, P. Mar, K. Pachmann, E. Thiel, B. Emmerich
      Pages 50-55
    7. I. Doxiadis, P. Dölken, M. E. Schneider, P. Wernet, H. Grosse-Wilde
      Pages 62-66
    8. W. Siegert, O. Josimovic-Alasevic, R. Schwerdtfeger, C. Schmidt, A. Neubauer, G. Henze et al.
      Pages 76-77
    9. D. Douer, I. Ben-Bassat, A. Kneller, S. D. Chitayat, N. Shaked, S. Salzberg et al.
      Pages 78-82
    10. W. Jelkmann, H. Johannsen, G. Wiedemann, M. Otte, T. Wagner
      Pages 83-86
    11. K. H. Pflüger, A. Grüber, M. Welslau, H. Köppler, K. Havemann
      Pages 87-94
    12. C. Schrader, M. Reuter, K. Mempel, W.-D. Ludwig, H. Riehm, G. Schellong et al.
      Pages 95-97
    13. J. P. M. Bökkerink, F. J. M. Damen, M. W. Hulscher, M. A. H. Bakker, R. A. De Abreu
      Pages 110-117
    14. J. D. Borsi, E. Sagen, I. Romslo, P. J. Moe
      Pages 118-121
    15. M. E. Scheulen, B. Kramer, M. Skorzec, W. K. Reich
      Pages 122-128
    16. C. Krehmeier, M. Zühlsdorf, Th. Büchner, W. Hiddemann
      Pages 129-132
    17. T. Urasiński, B. Gonet, K. Gnacińska, J. Peregud-Pogorzelski, W. Podraza, J. Fydryk
      Pages 137-140
    18. D. Lutz, H. Kasparu, H. Nowotny, E. Weber, O. Krieger, U. Köller et al.
      Pages 141-144
    19. I. Nölle, B. Schlegelberger, N. Schmitz, S. Bödewadt-Radzun, W. Grote
      Pages 145-149
    20. H. J. Weh, R. Hoffmann, S. Suciu, J. Ritter, R. Kuse, D. K. Hossfeld
      Pages 150-152
    21. J. Ritterbach, J. Harbott, J. Ritter, F. Lampert
      Pages 153-156
    22. G. Schaison, G. Leverger, A. Bernheim, M. T. Daniel, G. Flandrin, R. Berger
      Pages 157-158
    23. A. Reichle, M. Volkmann, K. Pachmann, H. Diddens, B. Emmerich, J. Rastetter
      Pages 159-165
    24. R. M. Slater, D. F. C. M. Smeets, A. Hagemeijer, B. De Jong, C. G. Beverstock, J. P. M. Geraedts et al.
      Pages 169-173
    25. M. Tsurusawa, N. Katano, T. Fujimoto
      Pages 174-181
  3. Acute Myelogenous Leukemia in Children

    1. Front Matter
      Pages 183-183
    2. H. E. Grier, R. D. Gelber, L. A. Clavell, B. M. Camitta, M. P. Link, M. J. Delorey Garcea et al.
      Pages 193-197
    3. C. P. Steuber, S. J. Culbert, Y. Ravindranath, J. Krischer, A. Ragab, C. Civin et al.
      Pages 198-209
    4. S. O. Lie, G. Berglund, G. Gustafsson, G. Jonmundsson, M. Siimes, M. Yssing
      Pages 215-221
    5. S. Amadori, A. Ceci, A. Comelli, E. Madon, G. Masera, L. Nespoli et al.
      Pages 222-225
    6. U. Creutzig, G. Niederbiermann, J. Ritter, J. Harbott, H. Löffler, G. Schellong
      Pages 226-232
    7. F. M. Fink, H. Gadner, E. R. Grümayer, G. Kardos, T. Revesz, Ch. Urban et al.
      Pages 233-236
  4. Acute Myelogenous Leukemia in Adults

    1. Front Matter
      Pages 237-237
    2. M. C. Petti, G. Broccia, F. Caronia, F. Di Raimondo, G. Fioritoni, S. Ladogana et al.
      Pages 249-253
    3. E. Kurrle, G. Ehninger, E. Fackler-Schwalbe, M. Freund, G. Heil, D. Hoelzer et al.
      Pages 254-260

About these proceedings

Introduction

Acute leukemia a quite homogenous disease failed to break through the sound barriere of when untreated reveals a substantial hetero­ unsatisfactory cure rates even in special sub­ geneity in its response to therapy. While cure groups. While new protocols including more is achieved in a certain proportion of pa­ effective supportive care show some increase tients other cases prove to be highly resis­ in the initial response rates and certain im­ tant. The curability is superior in acute provements in the long-term results, no ben­ lymphoblastic (ALL) than in acute myeloid eficial effect on the relapse rate during the (AML) leukemia and - within both type- first 1 Y2 years emerged from any of these higher in children as compared to adults. regimens. Thus, high chances for cure are The two age groups and cell types can be presently restricted to children with ALL further subdivided into prognostic groups and to lesser proportions children with by special diagnostic features. Thus, in AML and adults with ALL and AML.

Keywords

Akute Leukämie Knochenmarktransplantation adoptive Immuntherapie classification hämatopoetische Wachstumsfaktoren imaging morbidity

Editors and affiliations

  • T. Büchner
    • 1
  • G. Schellong
    • 1
  • W. Hiddemann
    • 1
  • J. Ritter
    • 1
  1. 1.Departments of Internal Medicine and PediatricsUniversity of MünsterMünsterFederal Republic of Germany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-74643-7
  • Copyright Information Springer-Verlag Berlin Heidelberg 1990
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-540-50984-4
  • Online ISBN 978-3-642-74643-7
  • Series Print ISSN 0440-0607
  • Buy this book on publisher's site